CLINICAL_TRIALS
trial_result
· 2019-01-30
Clinical Trial Update: Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects [Phase 1]
Summary
This completed Phase 1 study evaluated the safety, tolerability, and relative bioavailability of BMS-986195 in healthy subjects.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED